Andrew Ryan Clark, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8000 Fax: 610-799-8801 |
Dr. Ashleigh Anderson, DO Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8853 Fax: 610-799-8001 |
Stephen K Baker, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 843-412-2160 |
Welda T Donato Duque, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8800 Fax: 610-799-8424 |
Matthew S Koval, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 |
Dr. Kutaiba S Chaleby, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 610-799-8477 |
Dr. Amy Garner, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 5300 Kidspeace Dr, Orefield, PA 18069 Phone: 800-854-3123 Fax: 610-799-8801 |
News Archive
The cells of the human immune system are created from special stem cells in the bone marrow. In diseases affecting the bone marrow, such as leukemia, the degenerate cells must be destroyed using radiation or chemotherapy.
A coalition of AIDS organizations is asking the Obama administration to investigate whether some insurers are trying to discourage HIV-infected patients from enrolling in their policies by failing to cover some AIDS drugs or through what it called "egregious cost-sharing designs." Other stories explore the law's impact on African-Americans and small businesses.
Claraview, a division of Teradata Corporation, a strategy and technology consultancy focused on business intelligence and analytics, today announced the availability of its Healthcare Analytics Solutions for hospitals, clinics, physician-practices, long-term care facilities, pharmacy benefit managers and health insurers.
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight® Dx Pulmotax™ assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC," included 368 samples from carcinoma patients.
› Verified 8 days ago